Key facts
- MDinc’s last known valuation is $14.6M (Dec 2024).
- It has raised $2.2M; the latest was Angel (individual) ($2.2M) in Dec 2024.
- Notable investors include Abdulvadud Temirsultanov.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for MDinc
- ·The full record, as it builds
Funding rounds
No funding rounds for MDinc are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MDinc
Developer of a healthcare software designed for the treatment of nervous system diseases. The company's software has developed accessible and safe methods of nervous disease treatment using computer vision and machine learning, enabling patients to be provided with personalized treatment systems with the help of machine learning.
- Sector
- Healthcare
- HQ
- Moscow, Russia
- Founded
- 2016
- Employees
- 18
- Website
- mdinc.ru/
- Ownership
- Privately Held (backing)
MDinc doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MDinc shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MDinc in its N-PORT filings yet. We sweep new filings monthly.